Summary & Overview
CPT 0971T: Percutaneous Laser Ablation of Malignant Breast Tumor
CPT code 0971T represents percutaneous laser ablation of a malignant breast tumor and captures a minimally invasive, image-guided oncologic procedure performed on one breast. This treatment option has national relevance as image-guided ablation techniques expand as alternatives or adjuncts to surgical excision for selected breast malignancies, affecting utilization patterns, facility planning, and coverage policies.
Key payers included in the review are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise synthesis of clinical context, common billing considerations, and payer coverage trends where available. The publication outlines typical settings for the service (outpatient surgical centers, hospital outpatient departments, interventional radiology suites) and highlights benchmarks and policy topics relevant to payers and providers, including coding nuances and service-line implications.
This summary equips clinicians, billing professionals, and policy analysts with the essential background on the procedure and what to expect in payer interactions, documentation focus areas, and facility resource considerations. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 0971T describes percutaneous laser ablation of a malignant breast tumor, in which the provider uses laser energy to destroy tumor tissue. The procedure involves percutaneous access to the tumor and may use imaging guidance to ensure accurate targeting and complete ablation. This code applies to treatment of a single breast.
-
Service type: Percutaneous image-guided tumor ablation
-
Typical site of service: Outpatient surgical center or hospital outpatient department; may also be performed in specialized interventional radiology suites
Clinical & Coding Specifications
Clinical Context
A typical patient is a woman diagnosed with a localized primary malignant breast tumor who is not an immediate candidate for open surgical resection or elects a percutaneous, image‑guided ablative approach. The patient often presents after diagnostic mammography and core needle biopsy confirming malignancy (for example, early-stage invasive ductal carcinoma or a small recurrent tumor in a previously treated breast). Pre-procedure planning includes cross-sectional imaging (ultrasound, MRI, or contrast-enhanced CT as indicated), review of prior pathology, informed consent discussing risks and alternatives, and coordination with the multidisciplinary breast team.
The clinical workflow: pre-procedure evaluation and optimization (medical clearance, anticoagulation management), imaging localization and lesion targeting, percutaneous access under local anesthesia with conscious sedation or monitored anesthesia care, insertion of the laser ablation probe into the tumor under ultrasound or MRI guidance, delivery of laser energy to achieve tumor destruction with intraprocedural imaging confirmation, post‑ablation imaging to assess immediate treatment effect, hemostasis, and short recovery observation. Procedure documentation includes indication, laterality, imaging guidance modality, probe type, energy delivered, immediate complications, and post‑procedure disposition. The code 0971T is reported per breast treated (one unit for one breast).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |